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The paper reports that, over a 2-year time horizon, in the
Open Versus Endovascular Repair (OVER) trial, endovascular
repair was cost-effective.1 There was little difference in outcomes
between the open repair and endovascular repair (EVAR) groups
(whether measured by survival or by quality-adjusted life years).
However, the OVER trial found a mean difference of about $5900
in the costs of the primary hospitalization: $37,000 for EVAR and
$42,900 for open repair. The high cost per patient of endovascular
kit (about $14,000) was more than offset by cost savings in
intensive care, length of stay, laboratory tests, and use of medica-
tions. This initial difference in costs is maintained over 2 years,
although becomes less statistically significant, perhaps because of
attrition from the trial.
Are these findings either generalizable or relevant for current
clinical practice in theUnited States and in other health systems? In
some respects, the OVER trial should be more representative of
current practice than the earlier large-scale trials, EndoVascular
Aneurysm Repair trial 1 (EVAR 1) and Dutch Randomised Endo-
vascular Aneurysm Management (DREAM).2,3 The recruitment
period in OVER was 3 years later. Experience with EVAR has
increased, devices improved, and the length of stay after EVAR has
been reduced greatly since the earlier trials. However, it may be
difficult to transfer the results from this study to other settings.
The OVER trial was conducted only in Veterans Administra-
tion (VA) hospitals, and nearly all the patients were male. The
aneurysm size was smaller on average than previous trials. The results
are only reported up to 2 years. The 10-year results from EVAR 1
indicated that complications, reinterventions, and aneurysm-related
mortality were considerably greater after endovascular repair during
long-term followup.Longer-term results are awaited from theOVER
trial.
What is most surprising is the high cost of the primary hospi-
talization in the VA system. The cost exceeds the averageMedicare
reimbursement for abdominal aortic aneurysm repair in the Unitednd York, United Kingdom
tates by about $10,000.4 Medicare payments were substantially
igher at hospitals with high complication rates.4 There is no direct
vidence of high complication rates in the OVER trial, although
here is a suggestion that complication rates may have been high
fter open repair, with this group having excess hospital stay
waiting rehabilitation beds. Perhaps the skills for open repair are
aning as endovascular skills improve. The cost of primary hospi-
alization in the OVER trial was almost double the estimate from
VAR 1, after allowing for differences in general price levels
etween the two countries. International comparisons of costs are
otoriously difficult, as resource use and unit costs are partly
etermined by a wide set of factors beyond the control of hospitals.
sing cost-to-charge ratios may not reflect the true opportunity
osts of the resources used. Nevertheless, the question remains:
hy is aneurysm repair so expensive in VA hospitals? The findings
eported in this issue of the journal may not be translatable even to
ther, non-VA hospitals, in the United States.
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